Sugi Predict

Sugi Predict / Compounds / SCHEMBL201209

SCHEMBL201209

SCHEMBL201209

COc1ccc(C(=O)N2CC[C@@H](O)[C@H]2C(=O)NO)cc1SC(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ HTR2A P28223 2/20 0.35
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ROCK2 O75116 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TSHR P16473 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650506 1.00 PDK2 (0.39) PDK2ALDH1A1HTR2AKMT2AMEN1
SCHEMBL4650510 1.00 PDK2 (0.39) PDK2ALDH1A1HTR2AKMT2AMEN1
SCHEMBL13403420 0.87 PDK2 (0.43) PDK2ALDH1A1HTR2AKMT2AMEN1
SCHEMBL201024 0.83 ALDH1A1 (0.50) PDK2ALDH1A1ROCK2LMNAHSD11B1
SCHEMBL13403466 0.77 ALDH1A1 (0.41) PDK2ALDH1A1L3MBTL1GLALMNA
SCHEMBL1909511 0.76 MMP3 (0.50) TSHR
SCHEMBL13403452 0.75 HPGD (0.40) PDK2ALDH1A1L3MBTL1SLC6A4HRH3
SCHEMBL13403462 0.75 PDK2 (0.38) PDK2ALDH1A1SLC6A4HRH3
SCHEMBL13403467 0.74 KDM4E (0.37) PDK2ALDH1A1SLC6A4HRH3
SCHEMBL13403459 0.74 L3MBTL1 (0.42) PDK2ALDH1A1KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088804-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2012-01-03 — — US disclosed
US-8088804-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2012-01-03 — — US disclosed
US-8088804-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2012-01-03 — — US disclosed
EP-2338878-A2 N-hydroxyamide derivatives possessing antibacterial activity Vicuron Pharmaceuticals, Inc. (US) 2011-06-29 — — EP disclosed
US-20100022605-A1 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. 2010-01-28 — — US disclosed
US-20100022605-A1 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. 2010-01-28 — — US disclosed
US-20100022605-A1 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. 2010-01-28 — — US disclosed
WO-2007069020-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022605-A1 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY NAAA, HDHD5, HACL2 PDK2 4421/4885ALDH1A1 343/4885HTR2A 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.